--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About VTGN20260515C1
Pharmaceutical
Vistagen Therapeutics, Inc., founded on May 26, 1998, is a clinical-stage biopharmaceutical company dedicated to the development of a new generation of therapies for anxiety, depression and certain other central nervous system (CNS) diseases for which the current treatment options are insufficient, resulting in a large unmet need in a large and growing global market, The product line includes three clinical-stage CNS product candidates, PH94B, PH10 and AV-101, each with a different mechanism of action, superior safety in all clinical studies to date, and therapeutic potential in a variety of CNS indications.
